151 related articles for article (PubMed ID: 25201939)
41. Anticonvulsant use after formulary status change for brand-name second-generation anticonvulsants.
Patel H; Toe DC; Burke S; Rasu RS
Am J Manag Care; 2010 Aug; 16(8):e197-204. PubMed ID: 20690786
[TBL] [Abstract][Full Text] [Related]
42. Beliefs and attitudes about opioid prescribing and chronic pain management: survey of primary care providers.
Jamison RN; Sheehan KA; Scanlan E; Matthews M; Ross EL
J Opioid Manag; 2014; 10(6):375-82. PubMed ID: 25531955
[TBL] [Abstract][Full Text] [Related]
43. The medical office of the 21st century (MOXXI): effectiveness of computerized decision-making support in reducing inappropriate prescribing in primary care.
Tamblyn R; Huang A; Perreault R; Jacques A; Roy D; Hanley J; McLeod P; Laprise R
CMAJ; 2003 Sep; 169(6):549-56. PubMed ID: 12975221
[TBL] [Abstract][Full Text] [Related]
44. Determinants of physicians' prescribing behaviour of methylphenidate for cognitive enhancement.
Ponnet K; Wouters E; Van Hal G; Heirman W; Walrave M
Psychol Health Med; 2014; 19(3):286-95. PubMed ID: 23713799
[TBL] [Abstract][Full Text] [Related]
45. Prescriber compliance with black box warnings in older adult patients.
Ricci JR; Coulen C; Berger JE; Moore MC; McQueen A; Jan SA
Am J Manag Care; 2009 Nov; 15(11):e103-8. PubMed ID: 19895180
[TBL] [Abstract][Full Text] [Related]
46. Randomized Study of Providing Evidence Context to Mitigate Physician Misinterpretation Arising From Off-Label Drug Promotion.
Schwartz LM; Woloshin S; Lu Z; Ross KM; Tessema FA; Peter D; Kesselheim AS
Circ Cardiovasc Qual Outcomes; 2019 Nov; 12(11):e006073. PubMed ID: 31707825
[TBL] [Abstract][Full Text] [Related]
47. Impact of FDA Actions, DTCA, and Public Information on the Market for Pain Medication.
Bradford WD; Kleit AN
Health Econ; 2015 Jul; 24(7):859-75. PubMed ID: 25059655
[TBL] [Abstract][Full Text] [Related]
48. Is the prescribing behavior of Chinese physicians driven by financial incentives?
Chen C; Dong W; Shen JJ; Cochran C; Wang Y; Hao M
Soc Sci Med; 2014 Nov; 120():40-8. PubMed ID: 25218152
[TBL] [Abstract][Full Text] [Related]
49. Introduction to the new prescription drug labeling by the Food and Drug Administration.
Lal R; Kremzner M
Am J Health Syst Pharm; 2007 Dec; 64(23):2488-94. PubMed ID: 18029957
[TBL] [Abstract][Full Text] [Related]
50. Pharmacy compounding primer for physicians: prescriber beware.
Sellers S; Utian WH
Drugs; 2012 Nov; 72(16):2043-50. PubMed ID: 23039281
[TBL] [Abstract][Full Text] [Related]
51. Most primary care physicians are aware of prescription drug monitoring programs, but many find the data difficult to access.
Rutkow L; Turner L; Lucas E; Hwang C; Alexander GC
Health Aff (Millwood); 2015 Mar; 34(3):484-92. PubMed ID: 25732500
[TBL] [Abstract][Full Text] [Related]
52. US Food and Drug Administration Black Box Warnings.
Smith RG
J Am Podiatr Med Assoc; 2020 Jan; 110(1):Article10. PubMed ID: 32073327
[TBL] [Abstract][Full Text] [Related]
53. Ethical and Practical Considerations in Removing Black Box Warnings from Drug Labels.
Yeh JS; Sarpatwari A; Kesselheim AS
Drug Saf; 2016 Aug; 39(8):709-14. PubMed ID: 27000800
[TBL] [Abstract][Full Text] [Related]
54. Ethical issues in new drug prescribing.
Cole LW; Kesselheim JC; Kesselheim AS
J Bioeth Inq; 2012 Mar; 9(1):77-83. PubMed ID: 23180203
[TBL] [Abstract][Full Text] [Related]
55. HL7 Structured Product Labeling - electronic prescribing information for provider order entry decision support.
Schadow G
AMIA Annu Symp Proc; 2005; 2005():1108. PubMed ID: 16779395
[TBL] [Abstract][Full Text] [Related]
56. Contradictory actions on off-label use of prescription drugs? The FDA and CMS versus the U.S. Justice Department.
Curtiss FR; Fairman KA
J Manag Care Pharm; 2009 Mar; 15(2):161-5. PubMed ID: 19236131
[No Abstract] [Full Text] [Related]
57. Impact of the Pregnancy and Lactation Labeling Rule (PLLR) on Practicing Dermatologists.
Beroukhim K; Abrouk M; Farahnik B
Dermatol Online J; 2015 Nov; 21(11):. PubMed ID: 26632938
[TBL] [Abstract][Full Text] [Related]
58. Specific Prescribing Information for Geriatric Use in the 2019 Product Labeling for Novel New Drug Approvals.
Lisi DM
Sr Care Pharm; 2021 Sep; 36(9):455-465. PubMed ID: 34452655
[No Abstract] [Full Text] [Related]
59. Boxed warning inconsistencies between drug information resources and the prescribing information.
Cheng CM; Fu C; Guglielmo BJ; Auerbach AD
Am J Health Syst Pharm; 2011 Sep; 68(17):1626-31. PubMed ID: 21856808
[TBL] [Abstract][Full Text] [Related]
60. Multivariate Analysis of Physicians' Practicing Behaviors in an Urgent Care Telemedicine Intervention.
Liu S; Edson B; Gianforcaro R; Saif K
AMIA Annu Symp Proc; 2019; 2019():1139-1148. PubMed ID: 32308911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
